- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Choose Your Country or Region
Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Ireland
Israel
Italy
Japan
Korea
Luxembourg
Malaysia
Netherlands
New Zealand
Norway
Poland
Qatar
Romania
Saudi Arabia
Singapore
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
United States
| Catalog No. | Product Name | Information | Selective / Pan | IC50 / Ki |
|---|---|---|---|---|
| S6971 | Ervogastat | Ervogastat (PF-06865571, DGAT2i) is a potent diacylglycerol acyltransferase 2 (DGAT2) inhibitor that reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH). | Pan | |
| S9921 | PF-06424439 | PF-06424439 is a first orally bioavailable small-molecule inhibitor of DGAT2 with an IC50 of 14 nM. |
Pan | DGAT2, IC50: 14 nM |
| s7889 | Xanthohumol | Xanthohumol, a prenylated chalcone from hop, inhibits COX-1 and COX-2 activity and shows chemopreventive effects. Xanthohumol inhibits diacylglycerol acyltransferase 1 (DGAT1) and DGAT2 with both IC50 of 40 μM. Xanthohumol is also a potent antiviral agent against a series of DNA and RNA viruses. Xanthohumol induces growth inhibition and apoptosis in cancer cells. Phase 1. | Pan | DGAT2, IC50: 40 μM |
There are no products matching the selection yet, if you have any question please do not hesitate to contact us.
Selleck
Tech Support
Tel: +1-832-582-8158 Fax: +1-832-582-8590
Email: sales@selleckchem.com
Tel: +49 221 3579 1301
Email:eu.quote@selleckchem.com
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.